Potential for abuse among those with a known history of abuse or addiction may be lower with agonist-antagonists (eg, buprenorphine, butorphanol) than with pure agonists (eg, morphine, oxycodone, hydromorphone), but agonist-antagonist drugs have a ceiling effect for analgesia and induce a withdrawal syndrome in patients already physically dependent on opioids.